The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Morning all. I think Dave touched in this but how are we getting broker revenue forecasts for 2 products that won't be commercialised till next month, yet we had no revenue forecasts for the BC partnership- an established global distributor?
Also agree. Open offer shares - no benefit. Even new investors that take them will only be adding to dilution. Best to buy on open market if you want in.
Pacman it's because both the board and the company are trying to distant themselves from their failures to new PIs, hence no mention of the PCR testing on the broker note. They need to entice new PIs to take the shares from their mates at a profit, as well as the OO to existing investors to boost their coffers. Therefore they have picked figures from thin air for products which haven't even beeen launched, but said sweet FA about a product they had on the market gor 18 months.
*broker not board
Open offer won’t be taken up IMO unless the share price is much higher than it is now by the deadline. Absolutely shocked at the discount given for the placing - I had feeling there would probably be a placing to support the launch but not at that price. I have tons of questions, but right now I’m trying to figure out the likelihood of something triggering a rise before open offer deadline. I’m also wondering if the board new the market makers would open at the placing price last Thursday, I doubt it …as otherwise why would they think anyone would take up the open offer if they can buy on the open market without diluting their existing holdings. I’ve been away the past week, had even worse news last Thursday than the placing… but it’s been on my mind… and cost me a fortune in leveraged positions! I remember an open offer with (I think) Sound Energy 4 or 5 years ago that wasn’t taken up because share price fell below the offered price. Like most I’m now well down on my main holdings.
Lots of other thoughts, but will write when home. Like how could BC not sell anything? They were marketing in Europe too where FDA wasn’t needed, yet have they failed there too? We still don’t actually have any figures about how many they’ve sold. Only what genedrive have sold up to end of June.
HCV looks like it’s going to lose WHO… can’t they alter the test to avoid that happening? What they said about the POC test doesn’t sound that good either anymore, they’ve made the target market sound tiny. Just getting some initial thoughts off my chest, there’s obviously upside to be had over time (IMO) but we’ll annoyed. I started suspecting something wasn’t right with that Rt-PCR test when their office mate was using an alternative. Can’t understand why they haven’t reduced the cost, some profit is better than none - seems greed has been one of the problems.
Hello Jimi,
You made an interesting point about Sound Energy's actual share price falling below the placing value. If this happens to GDR and they fail to attract the 4.5m from the private investors, I wonder what would happen? Might they go back and ask more from the institutional investors? Cap in hand and begging bowl out?
I know that I am thinking of just averaging down via the open market naturally if I can get close to 25p or even slightly below 25p! This means I am not diluting my own investment.
Anyone else thinking same?
£6Mil is what they have raised to commercialise both AIHL and POC the OO for £4.5mil was to secure business cost and continue other lines of development (business costs = Bonuses)
Well that's a load BS Clark. Where are youbfetting these numbers from? AIHL took just £600k to develop so why does it need 5 times as much to launch, given the initial uptaje is going to be modest anyway.
Im not saying it will take that much im saying the placing for 6m is for the commercialisation and to keep the business running. 4.5m OO is extra and not linked
He got this over the line with iis who rinsed this last time. He might well be under playing the modest take up you mention? We will all have to wait and see!
Low to no volume will soon tell where this is going. As Jim mentioned the OO is not attractive for Pis to take up at these low prices.
Tine will tell
Well that's what you said your posts, read it again. The launches themselves will cost no more than £1.2m, the other £9m will go in the bank with the current £1.9m they have to pay them for the next 18 months ir so until they place again.
Suggest anyone that has a Twitter account, make your views known.
A good indication will be if there is an initial order in the CE marking of AIHL otherwise it will be another flop RNS
I swear by the Lord almighty this is not a RAMP but the whole truth and nothing but the truth so help me Budd. Could it be rather than there being No Sales, that the numbers are being surpressed until this is all out of the way. If I was an II and putting yet more wedge down I'd be asking that question. Clearly the numbers won't be vast but Divoc and whoever else are probably sat on some successes and given we know Budd is a devious C7unt there may be a semblance of some promise just around the corner IMO.
joke company. Db thinks he is running a cash printing machine in Novacyt so thinks he can pay himslef silly numbers and claim silly expenses
Franky - he’s got to have a fair idea on AIHL considering he’s expecting first sales in the Autumn.
Franky why do you still have tgis fantasy of the lack of sales is "DB downplaying things" The rampers have been saying this for months, which i've called out consistently. If there were any significant sales in the pipeline he would have known, and wouldn't have raised £10.50 and not at this pricepoint. Announcing significant sales straight after a placing, would straight away put him on the radar and prove him a fraud outright. He's not that stupid.
I spoke to my mate a few days ago and said i wonder if there will be a TR1 from the placing from Beckman?
Their Covid test is on many of the global webpages for Beckman inc Russia, China, Japan, Canada, USA. They are already marketing the "Forthcoming POC " test on Mountain Solutions. I honestly wonder if someone wants a slice of the cake to ensure they too benefit by helping a co the size of GDR move into the US market (and globally)
This is only my take on it.
Whats sales ££ have they had since the reporting date contained in that rns? Why didnt they say "sales have started to increase by XX% since the last trading update"
Ive run a number of businesses and as ive said before, Beckman would not market the products of a small co like GDR if they had not already assessed that they could buy the product. Something doesnt add up.
Also Finncap are now promoting the wonderful GDR products and such an exciting company
Ive just tweeted my response and tagged the FCA as did someone else as i tagged it @sackbudd - the tweet has already gone, forgot to copy it, (will remember in future) If your on Twitter - tweet your disgust and questions, tag FCA and add @sackbudd, they cant take the lot down
Hendi it’s like I said before , BC selling/stocking our products is like a large supermarket selling your goods , whilst it makes sales more likely unfortunately it’s not a guarantee
Still find it weird after I used that analogy that preefty told everyone he was one of the Main people in charge of how supermarkets get stocked to buy more when you shop
What makes it even weirder is when you challenged his f5 bashing on the BC website and seeing we appeared on a couple more searches and he claimed it was because of the large sales we were doing , he claimed to of known this because he coded/created big websites for multiple large companies
Don’t get me started when he claimed to be a psychologist to ffs haha
Hendi2- if it wasn't for DB's focus and drive GDR wouldn't be in even a half decent position....you're uneducated in business management I think. Why is it always who think they know who make comments...
Filtered.
If it wasn’t for DB’s ‘focus and drive’ or complete lack of it , we’d be a lot higher
You are incredibly deluded if you think DB has done a good job
Who are you longtermholder14?
Alan Sugar?
Not saying who is right or wrong though everyone is entitled to have an opinion!…it is a share chat platform after all.
You may have coded Preefty, but you were talking out your ass about any refinements to the webpages, suggesting the products is selling.
Because how much of a smugnorant ***** you was to anyone who didn’t agree with you , with your smarmy responses saying we are actively selling to 300k labs in America and any question you’d always just say BC have a Mcap of $6 billion totally avoiding any legit response
You was the classic if I said I went to Tenerife you’d been to elevenerife
As a recruiter of 25 years i can tell you off the bat what the problem is. DB s background is that of a molecular scientist. He is not a salesman and has risen to his level of incompetence. The problem is that you have to have a technical person leading the sales and so finding that hybrid skillset is incredibly difficult which is why you have someone being paid over the odds.